checkAd

     149  0 Kommentare ​​Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon​

    Lonza Group AG / Key word(s): Bond/Financing
    ​​Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon​

    08.02.2023 / 18:30 CET/CEST


    Basel, Switzerland, 08 February 2023 – Lonza Swiss Finance Ltd, a wholly owned company of Lonza Group Ltd, Basel (“Lonza”), announced today the pricing of a CHF 300 million straight-bond issue in line with its financing plan for 2023. The bond has a maturity of 6.5 years and an annual coupon of 2.100%.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Lonza Group AG!
    Long
    478,45€
    Basispreis
    5,02
    Ask
    × 10,70
    Hebel
    Short
    569,99€
    Basispreis
    0,56
    Ask
    × 9,59
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    The issuer is Lonza Swiss Finance Ltd, Basel, and the bonds will be guaranteed by Lonza. Lonza will apply for the listing of the bonds on the SIX Swiss Exchange. The proceeds of the bonds will be used for refinancing and general corporate purposes.

     

    Key Data

    Issue Size 6.5-Year Bond: CHF 300 million

    Expected Payment Date: 22 February 2023

    Maturity: 12 September 2029

    Issue Price: 100.241 percent

    Redemption Price: 100 percent

    Coupon: 2.100 percent p.a.

    Joint Lead Managers: Credit Suisse AG, UBS AG and Zürcher Kantonalbank

    About Lonza

    Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our business is structured to meet our customers' complex needs across four divisions: Biologics, Small Molecules, Cell & Gene and Capsules & Health Ingredients. Our unparalleled breadth of offerings across divisions enables our customers to commercialize their discoveries and innovations in the healthcare industry.

    Founded in 1897 in the Swiss Alps, today, Lonza operates across five continents. With approximately 17,500 full-time employees, we comprise high-performing teams and individual talent who make a meaningful difference to our own business, as well as to the communities in which we operate. The company generated sales of CHF 6.2 billion with a CORE EBITDA of CHF 2.0 billion in Full-Year 2022. Find out more at www.lonza.com

    Follow @Lonza on LinkedIn
    Follow @LonzaGroup on Twitter

    Lonza Contact Details

    Victoria Morgan
    Head of External Communications
    Lonza Group Ltd
    Tel +41 61 316 2283
    victoria.morgan@lonza.com

    Lyle Wheeler
    Investor Relations
    Lonza Group Ltd
    Tel +41 79 154 9522
    lyle.wheeler@lonza.com



    End of Media Release


    Language: English
    Company: Lonza Group AG
    Münchensteinerstrasse 38
    4052 Basel
    Switzerland
    Phone: +4161 316 81 11
    Internet: www.lonza.com
    ISIN: CH0013841017
    Valor: 1384101
    Listed: SIX Swiss Exchange
    EQS News ID: 1555389

     
    End of News EQS News Service

    1555389  08.02.2023 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1555389&application_name=news&site_id=wallstreet

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    ​​Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon​ Lonza Group AG / Key word(s): Bond/Financing ​​Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon​ 08.02.2023 / 18:30 CET/CEST Basel, Switzerland, 08 February 2023 – Lonza Swiss Finance Ltd, a wholly owned company of Lonza Group Ltd, …

    Schreibe Deinen Kommentar

    Disclaimer